Tick-borne Encephalitis and Possible Borrelial Serology

CompletedOBSERVATIONAL
Enrollment

690

Participants

Timeline

Start Date

January 1, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Tick Borne EncephalitisLyme Disease
Interventions
DRUG

Anti-borrelial antibiotic therapy

Beside symptomatic therapy, patients received oral doxycycline 100 mg (Doxy®) twice daily or ceftriaxone 2 g (Lendacin®) once daily for 14 days. Antibiotic therapy was left to the discretion of treating physicians. Patients reported the presence of nonspecific symptoms such as headache, fatigue, arthralgia, myalgia.

OTHER

No antibiotic.

Patients who received symptomatic therapy (paracetamol, Lekadol®, granisetron, Kytril®, metamizol, Analgin®, parenteral hydration with saline). Patients reported the presence of nonspecific symptoms such as headache, fatigue, arthralgia, myalgia.

Trial Locations (1)

Unknown

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
collaborator

University of Ljubljana School of Medicine, Slovenia

OTHER

lead

University Medical Centre Ljubljana

OTHER

NCT03958058 - Tick-borne Encephalitis and Possible Borrelial Serology | Biotech Hunter | Biotech Hunter